CellsMolecular BiologyPeer-reviewed journal article
Targeted control of gene expression using CRISPR-associated endoribonucleases
Sagar J. Parikh, Heather M. Terron, Luke A. BurgardiD, Derek S. Maranan, Dylan D. Butler, Abigail Wiseman, Frank M. LaFerlaiD, Shelley Lane, Malcolm A. LeissringiD
- Citations
- 1
- FWCI
- 0.30
- Field percentile
- 44th percentile
Abstract
CRISPR-associated endoribonucleases (Cas RNases) cleave single-stranded RNA in a highly sequence-specific manner, by recognizing and binding to short RNA sequences known as direct repeats (DRs). Here we investigate the potential of exploiting Cas RNases for the regulation of target genes with one or more DRs introduced into the 3 untranslated region, an approach we refer to as DREDGE (direct repeat-enabled down-regulation of gene expression). The DNase-dead version of Cas12a (dCas12a) was identified as the most efficient among 5 different Cas RNases tested and was subsequently evaluated in doxycycline-regulatable systems targeting either stably expressed fluorescent proteins or an endogenous gene. DREDGE performed superbly in stable cell lines, resulting in up to 90% downregulation with rapid onset, notably, in a fully reversible manner. Successful control of an endogenous gene with DREDGE was demonstrated in two formats, including one wherein both the DR and the transgene driving expression of dCas12a were introduced in one step by CRISPR-Cas. Our results establish DREDGE as an effective method for regulating gene expression in a targeted, highly selective, and fully reversible manner, with several advantages over existing technologies.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Programmable RNA Targeting using CasRx in Flies
A. Buchman, D. J. Brogan, … O. Akbari·bioRxiv·Apr 3, 2020
- CasTuner: a degron and CRISPR/Cas-based toolkit for analog tuning of endogenous gene expression
Gemma Noviello, Rutger A. F. Gjaltema, Edda G. Schulz·Nature CommunicationsPeer-reviewed·Jun 3, 2023
- Optimizing a CRISPR-Cas13d gene circuit for tunable target RNA downregulation with minimal collateral RNA cutting
Yiming Wan, Christopher Helenek, … Gábor Balázsi·ACS Synthetic BiologyPeer-reviewed·Oct 8, 2024
- DNA-guided CRISPR/Cas12 for RNA targeting
Carlos Orosco, Santosh R. Rananaware, … Piyush Jain·medRxiv·Nov 21, 2024
- Type III-A CRISPR systems as a versatile gene knockdown technology
W. T. Woodside, N. Vantsev, M. P. Terns·bioRxiv·Sep 25, 2020
- Suppression of unwanted CRISPR/Cas9 editing by co-administration of catalytically inactivating truncated guide RNAs
John C. Rose, Nicholas A. Popp, … Douglas M. Fowler·Nature CommunicationsPeer-reviewed·Jun 1, 2020